Skip to main content
P

PCL. Inc — Investor Relations & Filings

Ticker · 241820 ISIN · KR7241820000 KO Manufacturing
Filings indexed 681 across all filing types
Latest filing 2025-04-01 Regulatory Filings
Country KR South Korea
Listing KO 241820

About PCL. Inc

http://www.pclchip.com/

PCL, Inc. is a company that develops and manufactures in-vitro diagnostic (IVD) medical devices, specializing in multiplex immunodiagnosis. The company's core offering is based on its proprietary SG Cap™ Technology, a platform for creating advanced diagnostic solutions. Its product portfolio includes automated multi-immune diagnostic systems, blood testing kits, cancer screening tests, and rapid antigen kits. PCL also provides platform services, reagents, and related equipment such as desktop arrayers to the medical and diagnostic fields.

Recent filings

Filing Released Lang Actions
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from the Korean stock exchange (KRX) regarding a 'Correction Report' (정정신고) for a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). It details updates to a previously filed contract, specifically disclosing information that was previously withheld due to confidentiality. Since this is a specific regulatory disclosure regarding a commercial contract update and does not fit into categories like M&A or financial reports, it is classified as a general regulatory filing.
2025-04-01 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official report of the results of a General Meeting of Shareholders (정기주주총회결과) for the company PCL. It details the approval of financial statements, dividend decisions, and the election of directors and auditors. This falls under the category of Declaration of Voting Results & Voting Rights Announcements, as it provides the official outcome of the shareholder meeting.
2025-03-31 Korean
사업보고서 (2024.12)
Audit Report / Information Classification · 1% confidence The document is a comprehensive financial report titled '감사보고서' (Audit Report) for PCL Co., Ltd. It includes the independent auditor's report, financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes to the financial statements for the fiscal years 2023 and 2024. While it contains an audit report, the document is a full set of audited financial statements, which is the primary component of an Annual Report (10-K equivalent in this context). FY 2024
2025-03-24 Korean
[기재정정]분기보고서 (2024.09)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Correction Report' (정정신고) for a Quarterly Report (분기보고서) filed by PCL Inc. It contains detailed financial tables, including consolidated and separate summary financial information and statements of comprehensive income, comparing 'before' and 'after' figures due to an accounting adjustment (revenue recognition method). Since it provides substantive financial data and analysis for a specific interim period (3rd quarter), it is classified as an Interim/Quarterly Report. 9M 2024
2025-03-24 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed by the company PCL. It contains key financial data, audit opinions, and details regarding capital impairment and management's explanation of financial results. While it provides financial data, it is a regulatory filing submitted to the Korea Exchange (KRX) to announce the receipt and filing of the audit report, rather than the full annual report document itself. According to the 'Menu vs Meal' rule, this is a regulatory announcement of the audit report's availability. FY 2024
2025-03-24 Korean
반기또는분기매출액미달사실발생
Earnings Release Classification · 1% confidence The document is a regulatory disclosure regarding a failure to meet minimum revenue thresholds (700 million KRW for half-year and 300 million KRW for quarterly revenue). This is a specific regulatory filing required by the Korea Exchange (KRX) for listed companies to disclose financial status changes or compliance issues. Since it does not fit into standard financial reporting categories like 10-K or IR, and is a specific regulatory notification of a material event, it is classified as a Regulatory Filing (RNS). H2 2024
2025-03-24 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.